Akanksha Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Akanksha Sharma has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Aminul Islam
1 shared publicationAnup Kumar Keshri
1 shared publication- Budhi Singh
School of Mechanical Engineering, Sungkyunkwan University, Suwon, South Korea
1 shared publication - Jyotsna Mishra
Center for Research in Nanotechnology and Science, Indian Institute of Technology Bombay, Mumbai 400076, India
1 shared publication - Neha Redkar
Nanostructures Engineering and Modelling Laboratory, Department of Metallurgical Engineering and Materials Science, Indian Institute of Technology Bombay, Mumbai 400076, India
1 shared publication - Niranjan Pandit1 shared publication
Latest Publications
- Open Access
Nanobiotechnology-Based Strategies for Targeting Neuroinflammation and Neural Tissue Engineering
Neuroinflammation is a central hallmark of numerous neurological disorders, including Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, and spinal cord damage. Its persistent and dysregulated nature not only accelerates neuronal loss but also impedes endogenous repair, posing a major challenge for effective therapeutic intervention. Recent advances in nanobiotechnology have opened transformative opportunities to modulate neuroinflammation with unprecedented precision while simultaneously supporting neural regeneration. This review highlights emerging nanomaterial-based strategies including lipid-based, polymeric, inorganic nanoparticles designed to traverse the blood–brain barrier (BBB), deliver anti-inflammatory agents, modulate immune cell behavior, and attenuate glial activation. Extending beyond nanoparticle-based delivery systems, recent advances also emphasize the integration of nanomaterials into biomimetic architectures to provide structural and functional cues for neural repair. We further summarize how these functional nanostructured scaffolds, such as extracellular matrix (ECM) mimetic, nanofibrous and conductive hydrogels, are being leveraged in neural tissue engineering to direct stem cell fate, promote axonal outgrowth, and rebuild damaged neuroarchitectures. Moreover, pharmacokinetics, biodistribution, safety, clinical trials, regulatory considerations and limitations of nanotherapeutics in neurodegenerative diseases are discussed. By outlining the current progress, mechanistic insights, and translational challenges, this review underscores the potential of nanobiotechnology-enabled therapeutics to revolutionize the treatment of neuroinflammatory conditions and advance next-generation neural repair technologies.
Open AccessNanobiotechnology-Based Strategies for Targeting Neuroinflammation and Neural Tissue Engineering
Neuroinflammation is a central hallmark of numerous neurological disorders, including Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, and spinal cord damage. Its persistent and dysregulated nature not only accelerates neuronal loss but also impedes endogenous repair, posing a major challenge for effective therapeutic intervention. Recent advances in nanobiotechnology have opened transformative opportunities to modulate neuroinflammation with unprecedented precision while simultaneously supporting neural regeneration. This review highlights emerging nanomaterial-based strategies including lipid-based, polymeric, inorganic nanoparticles designed to traverse the blood–brain barrier (BBB), deliver anti-inflammatory agents, modulate immune cell behavior, and attenuate glial activation. Extending beyond nanoparticle-based delivery systems, recent advances also emphasize the integration of nanomaterials into biomimetic architectures to provide structural and functional cues for neural repair. We further summarize how these functional nanostructured scaffolds, such as extracellular matrix (ECM) mimetic, nanofibrous and conductive hydrogels, are being leveraged in neural tissue engineering to direct stem cell fate, promote axonal outgrowth, and rebuild damaged neuroarchitectures. Moreover, pharmacokinetics, biodistribution, safety, clinical trials, regulatory considerations and limitations of nanotherapeutics in neurodegenerative diseases are discussed. By outlining the current progress, mechanistic insights, and translational challenges, this review underscores the potential of nanobiotechnology-enabled therapeutics to revolutionize the treatment of neuroinflammatory conditions and advance next-generation neural repair technologies.
- 8 February 2022
- Published by Elsevier in Ceramics International
- Vol. 48 (10) , 14587-14595
Plasma-sprayed CeO2 overlay on YSZ thermal barrier coating: Solution for resisting molten CMAS infiltration
- 8 February 2022
- Published by Elsevier in Ceramics International
- Vol. 48 (10) , 14587-14595
Plasma-sprayed CeO2 overlay on YSZ thermal barrier coating: Solution for resisting molten CMAS infiltration
- 28 June 2018
- Published by Springer Nature in Journal of Electronic Materials
- Vol. 47 (9) , 5595-5600
Current Transport Mechanism in ZnO and Metal Phthalocyanine Based Inorganic/Organic Hybrid p–n Junction Diodes
- 28 June 2018
- Published by Springer Nature in Journal of Electronic Materials
- Vol. 47 (9) , 5595-5600
Current Transport Mechanism in ZnO and Metal Phthalocyanine Based Inorganic/Organic Hybrid p–n Junction Diodes